Tag: Protein kinase inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Protein kinase inhibitor

Non-Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2023 - Digital Journal

Added to Collection on: 2023-12-04 20:50:49

Tags for this article:

Lung cancer
KRAS
Genmab
Targeted therapy
Small-cell carcinoma
Seagen
Non-small-cell lung cancer
Protein kinase inhibitor
Cancer
Treatment of lung cancer
G1 Therapeutics
Non-Small Cell Lung Cancer

Click the tags to see associated articles and topics

View Article Details
Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital

Added to Collection on: 2024-01-05 21:48:51

Tags for this article:

Lung cancer
Quinazolines
Oncogenes
Tyrosine kinase receptors
Tyrosine-kinase inhibitor
Antineoplastic drugs
Epidermal growth factor receptor
Non-small-cell lung cancer
Protein kinase inhibitor
Afatinib
T790M

Click the tags to see associated articles and topics

View Article Details
ArriVent's Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window

Added to Collection on: 2024-01-26 16:48:04

Tags for this article:

Tyrosine kinase receptors
Epidermal growth factor receptor
Non-small-cell lung cancer
RET proto-oncogene
Amivantamab
Protein kinase inhibitor
Anaplastic lymphoma kinase
Lung cancer
ArriVent BioPharma

Click the tags to see associated articles and topics

View Article Details
Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists

Added to Collection on: 2024-02-05 16:47:40

Tags for this article:

Antineoplastic drugs
Cancer treatments
Immunology
HER2
Trastuzumab
Targeted therapy
Protein kinase inhibitor
Tyrosine-kinase inhibitor
Chemotherapy

Click the tags to see associated articles and topics

View Article Details
Iambic begins dosing in trial of IAM1363 for HER2-driven cancer

Added to Collection on: 2024-03-28 12:20:56

Tags for this article:

Tyrosine kinase receptors
Antineoplastic drugs
Breast cancer
HER2
Epidermal growth factor receptor
Triple-negative breast cancer
Trastuzumab
Tyrosine-kinase inhibitor
Protein kinase inhibitor
Lapatinib
Afatinib

Click the tags to see associated articles and topics

View Article Details
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B

Added to Collection on: 2024-04-27 19:02:23

Tags for this article:

Biotechnology
Orphan drugs
Medical physics
Cancer treatments
Lutetium (177Lu) oxodotreotide
Gene therapy
Cancer immunotherapy
Peptide receptor radionuclide therapy
BRAF
Protein kinase inhibitor
Neuroendocrine tumor
Radiation therapy
Pfizer

Click the tags to see associated articles and topics

View Article Details
Tagrisso Shows Significant Improvement in Progression-Free Survival in EGFRm NSCLC in ...

Added to Collection on: 2024-06-04 22:56:36

Tags for this article:

Lung cancer
Non-small-cell lung cancer
Osimertinib
T790M
Epidermal growth factor receptor
Gefitinib
Protein kinase inhibitor
Small-cell carcinoma
Adenocarcinoma of the lung
AstraZeneca Pharmaceuticals LP

Click the tags to see associated articles and topics

View Article Details
Exploring the Need for Second-Line Treatments in Thyroid Cancer - Targeted Oncology

Added to Collection on: 2024-06-12 18:07:39

Tags for this article:

Orphan drugs
Cyclopropanes
Chloroarenes
Ureas
Tyrosine kinase inhibitors
Thyroid cancer
Cabozantinib
Anaplastic thyroid cancer
Protein kinase inhibitor
Sorafenib
Lenvatinib
Thyroid
Cesar Augusto Perez

Click the tags to see associated articles and topics

View Article Details
Lorlatinib vs Crizotinib in Advanced ALK-Positive NSCLC: 5-Year Outcomes From Phase III ...

Added to Collection on: 2024-08-08 15:58:08

Tags for this article:

Fluoroarenes
Pyrazoles
Lung cancer
Tyrosine kinase receptors
CYP3A4 inhibitors
Lorlatinib
Crizotinib
Brain metastasis
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Survival rate
Protein kinase inhibitor
Benjamin J. Solomon

Click the tags to see associated articles and topics

View Article Details
Capmatinib in MET Exon 14–Mutated NSCLC - The ASCO Post

Added to Collection on: 2024-10-15 16:08:54

Tags for this article:

Antineoplastic drugs
Tyrosine kinase receptors
Orphan drugs
Lung cancer
Capmatinib
Tyrosine kinase inhibitors
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Epidermal growth factor receptor
Protein kinase inhibitor
Sunvozertinib
Aumolertinib

Click the tags to see associated articles and topics

View Article Details